46 results on '"Janot, F"'
Search Results
2. Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases
3. Paraneoplastic dermatomyositis accompanying nasopharyngeal carcinoma: Diagnosis, treatment and prognosis
4. 855MO Adjuvant immunotherapy after salvage surgery in head and neck cancer squamous cell carcinoma (HNSCC): Phase II trial evaluating the efficacy and the toxicity of Nivolumab (ADJORL1)
5. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx
6. SYM6 Microvascular Free Tissue Transfer in Pediatric Craniofacial Reconstruction
7. AcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types
8. What is the most effective treatment for head and neck squamous cell carcinoma? : An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups
9. Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases
10. Chemoradiotherapy versus radiotherapy in the treatment of salivary glands and nasal tumors: The GORTEC 2016-02 study
11. Erratum to “Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases” [Eur. Ann. Otorhinolaryngol. Head Neck Dis. 133 (1) (2016) 13–7]
12. Airway fire during tracheostomy
13. Hypodermal metastasis of malignant melanoma to the cheek
14. 109TiP - AcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types
15. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group
16. Comments on Wall-plug (AC) power consumption of a very high energy e+/e- storage ring collider' by Marc Ross
17. 1108TiP - Chemoradiotherapy versus radiotherapy in the treatment of salivary glands and nasal tumors: The GORTEC 2016-02 study
18. Results of Tpex (Docetaxel, Cisplatin, Cetuximab) Regimen Use in First Line Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M Scchn) in a Single Institution
19. 950O - Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group
20. Place du curage ganglionnaire après chimioradiothérapie dans les carcinomes épidermoïdes des voies aérodigestives supérieures avec atteinte ganglionnaire initiale (nasopharynx exclu).
21. Lebensqualität nach Tumorrezidiv-Chirurgie und Zweitbestrahlung bei Plattenepithelkarzinomen im Kopf-Hals-Bereich (GETTEC- und GORTEC-Gruppen)
22. Randomised trial of re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: Carcinologic and quality of life results GETTEC and GORTEC groups
23. Rezidiv-Chirurgie nach kombinierter Radiochemotherapie von Plattenepithelkarzinomen im Kopf- und Halsbereich
24. Re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomized trial from the GETTEC and GORTEC groups.
25. Docetaxel, Carboplatin and Fluoro-Uracil (TCF) Induction Therapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) Patients with Contraindication for Cisplatin Based Combination (TPF)
26. The Tolerance of TPF Chemotherapy Regime Standard or Modified in Head Neck Cancer Patients Over 65 Years Old
27. The Usefulness of G8 Evaluation in Therapeutic Decision and Prediction of Tolerance in Locally Advanced or Metastatic Squamous Cell Head and Neck Cancer (SCCHN) Patients Older Than 65 Years
28. Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas
29. Cytology vs molecular analysis for the detection of head and neck squamous cell carcinoma in oesopharyngeal brush samples: a prospective study in 56 patients
30. 997P - Results of Tpex (Docetaxel, Cisplatin, Cetuximab) Regimen Use in First Line Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M Scchn) in a Single Institution
31. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line
32. A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
33. Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma – a reply
34. Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study
35. Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis
36. Art d'élever les enfants à la maison , manuel d'éducation familiale
37. Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma.
38. Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy.
39. Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy.
40. Laryngo-esophageal Dysfunction-free Survival in a Preservation Protocol for T3 Laryngeal Squamous-cell Carcinoma.
41. A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network).
42. Molecular detection of early-stage laryngopharyngeal squamous cell carcinomas.
43. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma.
44. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
45. Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence.
46. Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.